Administrative Core
Administrative Core
批准号:
10554471
负责人:
THEODORE S LAWRENCE
金额:
$19.24万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-14 至 2028-07-31
关键词:
AccountabilityBiometryCancer CenterCancer PatientClinicalClinical ResearchClinical TrialsCommunicationCommunity OutreachComputational BiologyDataData Management ResourcesDevelopmentEnsureEvaluationFeedbackFosteringFutureHealthIndividualInstitutionLeadershipLocally Advanced Malignant NeoplasmMalignant NeoplasmsManuscriptsMichiganMolecular TargetNational Cancer InstituteOffice of Administrative ManagementPatientsPoliciesPopulationPreparationProcessRadiosensitizationRegulationResearchResearch ActivityResearch PersonnelResource InformaticsResourcesSchoolsScientistStructureTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesWorkcancer preventioncancer riskcancer therapyflexibilityhealth disparityinnovationmemberorganizational structureprogramsunderserved minority
中文摘要
项目摘要-摘要(管理核心)
密歇根大学分子靶向放射增敏的管理核心
局部晚期癌症孢子(放射增敏孢子)支持所有项目,核心,
以及孢子的发育程序。孢子有明确的定义和相互作用
包括明确定义的领导和咨询能力的组织结构
组织结构是为了满足孢子的特定目标,特别是为了促进
以最小的障碍和最大的灵活性提供高影响和创新的研究机会,
同时确保科学和预算决策的问责制和透明度。这个
行政核心促进所有孢子组成部分之间的深入沟通,以增强
研究整合,提供批判性科学反馈,评估科学进步,规划
未来的机会,并主张翻译的重点。
英文摘要
Project Abstract-Summary (Administrative Core)
The Administrative Core of the University of Michigan Molecularly Targeted Radiosensitization
of Locally Advanced Cancers SPORE (Radiosensitization SPORE) supports all projects, cores,
and developmental programs of the SPORE. The SPORE has well-defined and interactive
organizational structure that includes clearly defined leadership and advisory capabilities
organizational structure serves to meet the specific aims of the SPORE, especially to facilitate
high-impact and innovative research opportunities with minimal barriers and maximal flexibility,
while ensuring accountability and transparency in scientific and budgetary decisions. The
Administrative Core fosters in-depth communication among all SPORE components to enhance
research integration, provide critical scientific feedback, evaluate scientific progress, plan for
future opportunities, and assert translational focus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecularly Targeted Radiosensitization of Locally Advanced Cancers
-
批准号:10554470
-
项目类别:
-
资助金额:$206.62万
-
财政年份:2023
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors
-
批准号:10453984
-
项目类别:
-
资助金额:$58.14万
-
财政年份:2022
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors
-
批准号:10581670
-
项目类别:
-
资助金额:$57.97万
-
财政年份:2022
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Development of a first-in-class mEGFR dimerization inhibitor
-
批准号:10591476
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2020
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Development of a first-in-class mEGFR dimerization inhibitor
-
批准号:10435117
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2020
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Development of a first-in-class mEGFR dimerization inhibitor
-
批准号:10369006
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2020
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Development of a first-in-class mEGFR dimerization inhibitor
-
批准号:10778673
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2020
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response
-
批准号:9901492
-
项目类别:
-
资助金额:$58.21万
-
财政年份:2017
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
-
批准号:7891047
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2010
-
负责人:THEODORE S LAWRENCE
-
依托单位:
P3 - Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
-
批准号:7893334
-
项目类别:
-
资助金额:$11.08万
-
财政年份:2010
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
-
批准号:8242063
-
项目类别:
-
资助金额:$44.01万
-
财政年份:2010
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
-
批准号:8037021
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2010
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
-
批准号:8628073
-
项目类别:
-
资助金额:$23.17万
-
财政年份:2010
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
-
批准号:8850400
-
项目类别:
-
资助金额:$19.27万
-
财政年份:2010
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
-
批准号:8433504
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2010
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Gemcitabine-Radiation for Advanced Pancreatic Cancer
-
批准号:7810782
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2009
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Gemcitabine-Radiation for Advanced Pancreatic Cancer
-
批准号:7909157
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2009
-
负责人:THEODORE S LAWRENCE
-
依托单位:
Integration of EGFR Inhibitors with Radiochemotherapy
-
批准号:7448853
-
项目类别:
-
资助金额:$13.74万
-
财政年份:2008
-
负责人:THEODORE S LAWRENCE
-
依托单位:
HIGH DOSE RADIATION & HEPATIC ARTERIAL FLOXURIDINE IN INTRAHEPATIC MALIGNANCIES
-
批准号:7603701
-
项目类别:
-
资助金额:$5.97万
-
财政年份:2007
-
负责人:THEODORE S LAWRENCE
-
依托单位:
INDIVIDUALIZED DOSE ESCALATION IN VOLUME-EFFECT ORGANS
-
批准号:7082534
-
项目类别:
-
资助金额:$26.57万
-
财政年份:2006
-
负责人:THEODORE S LAWRENCE
-
依托单位:
海外基金